- Home
- XENE vs TAC Comparison
XENE vs TAC Comparison
Compare XENE & TAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- TAC
- Stock Information
- Founded
- XENE 1996
- TAC 1909
- Country
- XENE Canada
- TAC Canada
- Employees
- XENE N/A
- TAC N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- TAC Electric Utilities: Central
- Sector
- XENE Health Care
- TAC Utilities
- Exchange
- XENE Nasdaq
- TAC Nasdaq
- Market Cap
- XENE 3.0B
- TAC 3.1B
- IPO Year
- XENE 2014
- TAC N/A
- Fundamental
- Price
- XENE $42.23
- TAC $10.31
- Analyst Decision
- XENE Strong Buy
- TAC
- Analyst Count
- XENE 10
- TAC 0
- Target Price
- XENE $57.30
- TAC N/A
- AVG Volume (30 Days)
- XENE 367.1K
- TAC 829.9K
- Earning Date
- XENE 11-12-2024
- TAC 11-05-2024
- Dividend Yield
- XENE N/A
- TAC 1.68%
- EPS Growth
- XENE N/A
- TAC N/A
- EPS
- XENE N/A
- TAC 0.38
- Revenue
- XENE N/A
- TAC $2,065,953,587.00
- Revenue This Year
- XENE N/A
- TAC N/A
- Revenue Next Year
- XENE $1,600.08
- TAC N/A
- P/E Ratio
- XENE N/A
- TAC $26.97
- Revenue Growth
- XENE N/A
- TAC N/A
- 52 Week Low
- XENE $28.10
- TAC $5.94
- 52 Week High
- XENE $50.99
- TAC $11.11
- Technical
- Relative Strength Index (RSI)
- XENE 48.00
- TAC 44.50
- Support Level
- XENE $41.42
- TAC $9.98
- Resistance Level
- XENE $44.61
- TAC $11.11
- Average True Range (ATR)
- XENE 1.40
- TAC 0.41
- MACD
- XENE -0.15
- TAC -0.08
- Stochastic Oscillator
- XENE 25.94
- TAC 40.93
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.
About TAC TransAlta Corporation
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse and growing fleet of electrical power generation assets in Canada, the United States, and Australia. The company has six reportable segments namely, hydro, wind & solar, Energy Marketing, gas, energy transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.